Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;63(12):e8-e18.
doi: 10.1111/jgs.13807. Epub 2015 Oct 8.

Alternative Medications for Medications in the Use of High-Risk Medications in the Elderly and Potentially Harmful Drug-Disease Interactions in the Elderly Quality Measures

Affiliations

Alternative Medications for Medications in the Use of High-Risk Medications in the Elderly and Potentially Harmful Drug-Disease Interactions in the Elderly Quality Measures

Joseph T Hanlon et al. J Am Geriatr Soc. 2015 Dec.

Abstract

The National Committee for Quality Assurance (NCQA) and the Pharmacy Quality Alliance (PQA) use the American Geriatrics Society (AGS) Beers Criteria to designate the quality measure Use of High-Risk Medications in the Elderly (HRM). The Centers for Medicare and Medicaid Services (CMS) use the HRM measure to monitor and evaluate the quality of care provided to Medicare beneficiaries. NCQA additionally uses the AGS Beers Criteria to designate the quality measure Potentially Harmful Drug-Disease Interactions in the Elderly. Medications included in these measures may be harmful to elderly adults and negatively affect a healthcare plan's quality ratings. Prescribers, pharmacists, patients, and healthcare plans may benefit from evidence-based alternative medication treatments to avoid these problems. Therefore the goal of this work was to develop a list of alternative medications to those included in the two measures. The authors conducted a comprehensive literature review from 2000 to 2015 and a search of their personal files. From the evidence, they prepared a list of drug-therapy alternatives with supporting references. A reference list of nonpharmacological approaches was also provided when appropriate. NCQA, PQA, the 2015 AGS Beers Criteria panel, and the Executive Committee of the AGS reviewed the drug therapy alternatives and nonpharmacological approaches. Recommendations by these groups were incorporated into the final list of alternatives. The final product of drug-therapy alternatives to medications included in the two quality measures and some nonpharmacological resources will be useful to health professionals, consumers, payers, and health systems that care for older adults.

Keywords: Beers Criteria; inappropriate medications; medication management.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The editor in chief has reviewed the conflict of interest checklist provided by the authors and has determined that the authors have no financial or any other kind of personal conflicts with this paper. Todd P. Semla receives honoraria from the AGS and LexiComp, Inc. He is a member of Omnicare, Inc. Pharmacy and Therapeutics Committee (consultant). His spouse is an employee of AbbVie and owns stock in AbbVie, Abbott Labs, and Hospira.

References

    1. Huisman-Baron M, van der Veen L, Jansen PAF, et al. Criteria for drug selection in frail elderly persons. Drugs Aging. 2011;28:391–402. - PubMed
    1. NCQA. [Accessed April 23, 2015];HEDIS 2015 Final NDC Lists [on-line] Available at http://www.ncqa.org/HEDISQualityMeasurement/HEDISMeasures/HEDIS2015/HEDI....
    1. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. AGS Updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616–631. - PMC - PubMed
    1. O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age Ageing. 2015;44:213–218. - PMC - PubMed
    1. Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc. 2007;55:S373–S382. - PubMed

APPENDIX I. References for Alternative Medications Included in Table 1

    1. Hansen J, Klimek L, Hörmann K. Pharmacological management of allergic rhinitis in the elderly: Safety issues with oral antihistamines. Drugs Aging. 2005;22:289–296. - PubMed
    1. Cardona V, Guilarte M, Luengo O, et al. Allergic diseases in the elderly. Clin Transl Allergy. 2011;1:1. - PMC - PubMed
    1. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy. 2008;63(Suppl 86):8–160. - PubMed
    1. Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy. 2008;38:19–42. - PMC - PubMed
    1. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol. 2008;122(Suppl 2):S1–S84. - PubMed

APPENDIX II. References for Alternative Medications Included in Table 2

    1. Pugh MJ, Berlowitz DR, Rao JK, et al. The quality of care for adults with epilepsy: An initial glimpse using the QUIET measure. BMC Health Serv Res. 2011;11:1. - PMC - PubMed
    1. Correll CM, Bazil CW. Management of seizures in the elderly. Curr Geri Rep. 2014;3:73–82.
    1. Werhahn KJ, et al. A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy. Epilepsia. 2015;56:450–459. - PubMed
    1. Dworkin RH, O’Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain. 2007;132:237–251. - PubMed
    1. Moulin DE, Clark AJ, Gilron I, et al. Pharmacological management of chronic neuropathic pain—consensus statement and guidelines from the Canadian Pain Society. Pain Res Manage. 2007;12:13–21. - PMC - PubMed

APPENDIX III. Resources for Nonpharmacological Alternatives to Medications Included in the Use of High-Risk Medications in the Elderly and Potentially Harmful Drug–Disease Interactions in the Elderly Quality Measures

    1. Holroyd-Leduc J, Reddy M, editors. Evidence-Based Geriatric Medicine. BMJ Books; 2012.
    1. Reuben DB, Herr KA, Pacala JT, et al. Geriatrics at Your Fingertips: 2015. 17. New York: American Geriatrics Society; 2015.
    1. Abraha I, Cruz-Jentoft A, Soiza RL, et al. Evidence of and recommendations for non-pharmacological interventions for common geriatric conditions: The SENATOR-ONTOP systematic review protocol. BMJ Open. 2015;5:e007488. - PMC - PubMed
    1. Durso SC, Sullivan GM, editors. Geriatrics Review Syllabus: A Core Curriculum in Geriatric Medicine. 8. New York: American Geriatrics Society; 2013.
    1. Hanson LC, Ersek M, Gilliam R, et al. Oral feeding options for people with dementia: A systematic review. J Am Geriatr Soc. 2011;59:463–472. - PMC - PubMed

LinkOut - more resources